The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
RDT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

13 Jan 2022 07:00

RNS Number : 2786Y
Rosslyn Data Technologies PLC
13 January 2022
 

Rosslyn Data Technologies plc

("RDT", the "Group" or the "Company")

Trading update

RDT provides the following trading update.

2021 marked the start of a transformational period for Rosslyn. Following the appointment of Paul Watts as CEO in April 2021, a new leadership team has been put in place and a full operational review has been conducted in order to ensure that the business is able to provide solutions to the continually evolving needs of its customer base.

With an increased corporate focus on supply chain resilience, risk and sustainability, RDT's clients are placing more focus on procurement savings and efficiencies and the Board believes that the Group's core RAPiD product is becoming ever more relevant.

Accordingly, the Board has focused its efforts and invested heavily on developing the next generation of the Group's core RAPiD product, which it will launch before the end of March 2022. The product is currently in beta testing and the Board is extremely pleased that feedback, so far, has been overwhelmingly positive. The next generation of the RAPiD product includes, amongst other things:

· a transformation of the UI/UX interface to expand user adoption across a much broader range of procurement professionals;

· a move towards a pure best of breed cloud delivery;

· a foundation architecture built to deliver advanced intelligent automation and machine learning into the category management functions; and

· an enhancement to the product's data mining capability into a specific product called Data Factory.

Delivering growth and profitability in RDT's core market is the Board's key priority, and the operational review focused on how best to achieve this. The review identified that the Integritie and Langdon Systems acquisitions, whilst performing well since they became part of the Group, have limited crossover in terms of customer base or strategic rationale. As a result, the Board will continue to consider how to best capitalize on the Group's core business, which may include the divestment of these non-core elements of the Group, in order to deliver the best value to shareholders as a whole. The Board believes that following a strategy to enable RDT to operate as a single market data company, focused on procurement with a dynamic in-house operating model and culture will best position the Group to drive growth and deliver shareholder value in the medium to long term.

During the year, the Group has invested in its growth, with a number of key hires being made, whilst also remaining disciplined on costs and the Board will continue to explore ways to minimise costs.

The Group has made good progress so far this financial year, including winning deals for a top 10 global pharmaceutical business, a top 3 global beverage company, and a top 5 UK Law firm. At the same time, there has been a focus on exiting non-profitable business lines, to enable the Company to focus on larger, more profitable contracts. However, and as has been reported previously, larger contracts have lengthy lead times and Covid restrictions that have been experienced across the economy have lengthened these further. Whilst the Company will continue to work hard to secure further contracts before the end of the financial year, the challenges being faced, mean that the Board is taking a more conservative view on the outcome for the year ending 30 April 2022 and now expects revenue to be no less than £6.0m, with ARR to be at least £5.1m and a corresponding impact on EBITDA.

Paul Watt, CEO, commenting, "Like many businesses we have not been immune to the effects of the pandemic and this is reflected in our anticipated financial performance for the current calendar year. However, with a refreshed leadership team, a great core product and a clear strategy now in place I believe that there are significant opportunities available to the Group to drive growth and deliver shareholder value and am excited to look to the future."

 

This announcement contains inside information.

 

 

 

 

Rosslyn Data Technologies plc

Paul Watts, Chief Executive Officer

+44(0) 7555 144983+44(0)20 3285 8008

James Appleby, Chairman

+44 (0) 7940 560624

Cenkos Securities,Nominated Adviser, Broker

Stephen Keys/Camilla Hume/Giles Balleny

 

+44(0)20 7397 8900

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKLLFFLFLBBBK
Date   Source Headline
28th Mar 202412:56 pmRNSHolding(s) in Company
28th Mar 202412:55 pmRNSHolding(s) in Company
6th Mar 202411:49 amRNSHolding(s) in Company
4th Mar 202411:47 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSTrading Update
25th Jan 20246:07 pmRNSReplacement- Interim Results
25th Jan 20247:00 amRNSInterim Results
12th Jan 20249:54 amRNSHolding(s) in Company
12th Jan 20249:52 amRNSHolding(s) in Company
4th Jan 20242:21 pmRNSChange of Registered Address
12th Dec 202311:24 amRNSChange of Nominated Adviser and Broker
8th Dec 20234:42 pmRNSHolding(s) in Company
24th Nov 202312:43 pmRNSHolding(s) in Company
23rd Nov 20231:31 pmRNSResult of AGM
31st Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
27th Oct 20234:15 pmRNSHolding(s) in Company
17th Oct 202312:46 pmRNSHolding(s) in Company
17th Oct 202310:10 amRNSHolding(s) in Company
5th Oct 202310:21 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSDirectorate Change
26th Sep 202311:08 amRNSHolding(s) in Company
25th Sep 20235:28 pmRNSTR1 - NOTIFICATION OF MAJOR HOLDINGS
25th Sep 20234:51 pmRNSHolding(s) in Company
25th Sep 20233:52 pmRNSHolding(s) in Company
22nd Sep 202311:52 amRNSHolding(s) in Company
21st Sep 202312:43 pmRNSHolding(s) in Company
21st Sep 202312:37 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSShare Consolidation and Total Voting Rights
19th Sep 20238:07 amRNSDirector Dealings
18th Sep 202312:09 pmRNSResult of General Meeting
5th Sep 20235:02 pmRNSResult of Retail Offer
31st Aug 20237:00 amRNSResult of Placing and Posting of Circular
30th Aug 20234:35 pmRNSRetail Offer
30th Aug 20234:30 pmRNSProposed Placing, Loan Note Issue & Notice of GM
30th May 20237:00 amRNSRosslyn wins two new contracts
11th Apr 20234:40 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSTrading Update
9th Mar 20239:48 amRNSHolding(s) in Company
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20239:05 amRNSSecond Price Monitoring Extn
31st Jan 20239:00 amRNSPrice Monitoring Extension
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
30th Jan 20237:00 amRNSRosslyn wins new multi-year contract
30th Jan 20237:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.